中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Riboflavin and its degradation product from Carthamus tinctorius

文献类型:期刊论文

作者Li Feng; He Zhisheng; Ye Yang
刊名Chinese Traditional and Herbal Drugs
出版日期2004
卷号35期号:3页码:247-249
关键词Carthamus tinctorius L. Compositae riboflavin nucleoside
ISSN号0253-2670
其他题名红花中核黄素及其降解产物
文献子类Article
英文摘要Object To carry out a systematic study on the chemical constituents of Carthamus tinctorius L. In order to reveal pharmacological active compounds for their further development. Methods Three constituents were separated by macroporous resin, silica gel? polyamide, Sephadex LH-20 and spectral analysis. Results The structures were elucidated by spectroscopic means including ID, 2D NMR and ESI-MS; they are l-ribityl-2, 3-diketo-1, 2, 3, 4-tetrahydro-6, 7-dimethyl-quinoxaline ( I ), riboflavin ( I ) , and uracil-ribofuranose ( I ). Conclusion Compounds I - I are isolated from C tinctorius for the first time. Compound I is a very important coenzyme for our bodies. It has been found that compound I has the property of lowering the blood pressure of anesthetized dogs when administered in travenously.
资助项目国家自然科学基金资助项目[00000000]
WOS研究方向General & Internal Medicine (provided by Clarivate Analytics)
语种中文
CSCD记录号CSCD:1611368
源URL[http://119.78.100.183/handle/2S10ELR8/268383]  
专题药物安全性评价中心
作者单位State Key Laboratory of Drug Research, Institute of Materia Medica, Shanghai Institute for Life Science, Chinese Academy of Sciences, Shanghai 201203, China.
推荐引用方式
GB/T 7714
Li Feng,He Zhisheng,Ye Yang. Riboflavin and its degradation product from Carthamus tinctorius[J]. Chinese Traditional and Herbal Drugs,2004,35(3):247-249.
APA Li Feng,He Zhisheng,&Ye Yang.(2004).Riboflavin and its degradation product from Carthamus tinctorius.Chinese Traditional and Herbal Drugs,35(3),247-249.
MLA Li Feng,et al."Riboflavin and its degradation product from Carthamus tinctorius".Chinese Traditional and Herbal Drugs 35.3(2004):247-249.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。